
Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 25, 2021, titled "Zydus Desidustat shows efficacy and safety in treating Hypoxia in hospitalized Covid-19 patients in Mexico".
Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 25, 2021, titled "Zydus Desidustat shows efficacy and safety in treating Hypoxia in hospitalized Covid-19 patients in Mexico".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences